Researchers find less risky way to monitor breast cancer progression

by CU Anschutz Medical CampusSchematic for identifying subset of binding sites with TF footprints. (A) When TFs or nucleosomes are bound at TFBSs, they protect different lengths of DNA from nucle

Updated on: February 20,2024

Researchers find less risky way to monitor breast cancer progression

by CU Anschutz Medical CampusSchematic for identifying subset of binding sites with TF footprints. (A) When TFs or nucleosomes are bound at TFBSs, they protect different lengths of DNA from nucle

Updated on:February 20,2024

New cancer therapy takes personalized medicine to a new level

by Karen WeintraubCredit: Unsplash/CC0 Public DomainPersonalized care has been a buzzword in medicine for years, but new research on cancer treatment is taking it to a new level.Detailed in a study pu

Updated on: January 11,2024

New cancer therapy takes personalized medicine to a new level

by Karen WeintraubCredit: Unsplash/CC0 Public DomainPersonalized care has been a buzzword in medicine for years, but new research on cancer treatment is taking it to a new level.Detailed in a study pu

Updated on:January 11,2024

Newly discovered mechanism helps tumor cells evade the immune system early on

byTechnical University MunichDr. Jan Böttcher, group leader and TUM Junior Fellow at the Institute of Molecular Immunology at Klinikum rechts der Isar (left) and doctoral student Sebastian Lache

Updated on: April 28,2024

Newly discovered mechanism helps tumor cells evade the immune system early on

byTechnical University MunichDr. Jan Böttcher, group leader and TUM Junior Fellow at the Institute of Molecular Immunology at Klinikum rechts der Isar (left) and doctoral student Sebastian Lache

Updated on:April 28,2024

Pembrolizumab aids survival with high-risk endometrial cancer

by Lori SolomonPembrolizumab plus chemotherapy improves disease-free survival (DFS) in patients with high-risk endometrial cancer after surgery with curative intent, according to a study published onl

Updated on: November 09,2024

Pembrolizumab aids survival with high-risk endometrial cancer

by Lori SolomonPembrolizumab plus chemotherapy improves disease-free survival (DFS) in patients with high-risk endometrial cancer after surgery with curative intent, according to a study published onl

Updated on:November 09,2024

Overall cancer mortality continues to decline

by National Cancer InstituteCredit: CC0 Public DomainThe latest Annual Report to the Nation on the Status of Cancer finds that, for all cancer sites combined, cancer death rates continued to decl

Updated on: April 01,2024

Overall cancer mortality continues to decline

by National Cancer InstituteCredit: CC0 Public DomainThe latest Annual Report to the Nation on the Status of Cancer finds that, for all cancer sites combined, cancer death rates continued to decl

Updated on:April 01,2024

Study gauges specific site stomach cancer risks among ethnic groups

by Vanderbilt University Medical CenterCredit: CC0 Public DomainNon-white Americans, especially Asian Americans, are at disproportionately higher risk for gastric cancer compared to non-Hispanic

Updated on: April 20,2024

Study gauges specific site stomach cancer risks among ethnic groups

by Vanderbilt University Medical CenterCredit: CC0 Public DomainNon-white Americans, especially Asian Americans, are at disproportionately higher risk for gastric cancer compared to non-Hispanic

Updated on:April 20,2024

An exosome-based liquid biopsy shows promise for early detection of pancreatic cancer

byAmerican Association for Cancer ResearchPancreatic cancer cells (blue) growing as a sphere encased in membranes (red). Credit: National Cancer InstituteAn investigational exosome-based liquid

Updated on: April 28,2024

An exosome-based liquid biopsy shows promise for early detection of pancreatic cancer

byAmerican Association for Cancer ResearchPancreatic cancer cells (blue) growing as a sphere encased in membranes (red). Credit: National Cancer InstituteAn investigational exosome-based liquid

Updated on:April 28,2024

A myeloma-targeting monoclonal antibody offers new hope for treating multiple myeloma

by Osaka UniversitySummary of the research. Credit: Naoki HosenMultiple myeloma (MM) is a largely incurable cancer of plasma cells with an extremely poor prognosis. However, investigators from Ja

Updated on: May 07,2024

A myeloma-targeting monoclonal antibody offers new hope for treating multiple myeloma

by Osaka UniversitySummary of the research. Credit: Naoki HosenMultiple myeloma (MM) is a largely incurable cancer of plasma cells with an extremely poor prognosis. However, investigators from Ja

Updated on:May 07,2024

Experimental cancer therapy shows success in more than 70% of patients in global clinical trials

by The Mount Sinai HospitalCredit: Unsplash/CC0 Public DomainA new therapy that makes the immune system kill bone marrow cancer cells was successful in as many as 73% of patients in two clinical

Updated on: February 18,2024

Experimental cancer therapy shows success in more than 70% of patients in global clinical trials

by The Mount Sinai HospitalCredit: Unsplash/CC0 Public DomainA new therapy that makes the immune system kill bone marrow cancer cells was successful in as many as 73% of patients in two clinical

Updated on:February 18,2024

Growth in plant-based foods industry is slowing: Where does it go from here?

by Brooks Johnson, Star TribuneCredit: Unsplash/CC0 Public DomainWhen Willa's Oat Milk launched five years ago, the plant-based market was rapidly expanding, attracting unprecedented attention and

Updated on: April 10,2024

Growth in plant-based foods industry is slowing: Where does it go from here?

by Brooks Johnson, Star TribuneCredit: Unsplash/CC0 Public DomainWhen Willa's Oat Milk launched five years ago, the plant-based market was rapidly expanding, attracting unprecedented attention and

Updated on:April 10,2024

Secret vulnerabilities of cancer's 'Death Star' protein revealed

byCenter for Genomic RegulationA three-dimensional image showing the human protein KRAS (blue) interacting with RAF1 (yellow), one of its main partners. The blue-to-red colour gradient indicates

Updated on: December 30,2023

Secret vulnerabilities of cancer's 'Death Star' protein revealed

byCenter for Genomic RegulationA three-dimensional image showing the human protein KRAS (blue) interacting with RAF1 (yellow), one of its main partners. The blue-to-red colour gradient indicates

Updated on:December 30,2023

Cancer risk found to be higher in asthma patients

by Lori SolomonPeople with asthma are more likely to develop cancer, particularly those not using inhaled steroids, according to a study published online March 31 inCancer Medicine.Yi Guo, Ph.D.

Updated on: January 11,2024

Cancer risk found to be higher in asthma patients

by Lori SolomonPeople with asthma are more likely to develop cancer, particularly those not using inhaled steroids, according to a study published online March 31 inCancer Medicine.Yi Guo, Ph.D.

Updated on:January 11,2024